Although C1-INH has not been validated in DKD patients, a randomized and placebo-controlled trial indicated patients at a high risk of delayed graft function (DGF) after kidney transplantation required fewer dialysis sessions and had a higher glomerular filtration rate at a 1-year follow-up after treated with C1-INH (59). Here, SERPING1 is linked to diabetic kidney disease.